Interleukin-1 and the immunogenetics of Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 6, 2000, Pages 471-476

  Mrak, Robert E ^a,b   Griffin, W S T ^a,b,c,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

Alzheimer disease; Genetics; Inflammation; Interleukin 1; Polymorphisms

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; INTERLEUKIN 1; PRESENILIN 1; PRESENILIN 2;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DNA POLYMORPHISM; GENE OVEREXPRESSION; GENETIC RISK; HUMAN; IMMUNOGENETICS; PRIORITY JOURNAL;

EID: 0034045148     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.6.471     Document Type: Article

References (74)

1. Goate A, Chartier-Harlin M-C, Mullan M. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-6
2. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene hearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60
3. Rogaev EI, Sherrington R, Rogaeva EA. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome I related to the Alzheimer's disease type 3 gene. Nature 1995;376: 775-78
4. Saunders AM, Strittmatter WJ, Sehmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72
5. 2-Macroglobulin is genetically associated with Alzheimer disease. Nature Genet 1998;19: 357-60
6. Okuizumi K, Onodera O, Namba Y, et al. Genetic association of the very low-density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genet 1995;11:207-9
7. Chung H, Roberts CT, Greenberg S, et al. Lack of association of trinucleotide repeat polymorphisms in very low-density lipoprotein receptor gene with Alzheimer's disease. Ann Neurol 1996;39: 800-803
8. Lehman DJ, Johnston C, Smith AD. Synergy between the gene for hutyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer Disease. Hum Mol Genet 1997;6:1933-36
9. Brindle N, Song Y, Rogaeva E, et al. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease. Hum Molec Genet 1998;7:933-35
10. Singleton AB, Smith G, Gibson AM, et al. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Molec Genet 1998;7:937-39
11. 1-antichymotrypsin polymorphism. Nature Genet 1995;10:486-88
12. Talbot C, Houlden H, Craddock N, et al. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. Neuroreport 1996;7:534-36
13. 1-antichymotrypsin polymorphism in Alzheimer's disease. Ann Neurol 1996;40:678-80
14. 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum Genet 1997;99:27-31
15. Schellenberg GD, Payami H, Wijsman EM, et al. Chromosome 14 and late-onset familial Alzheimer disease (FAD). Am J Hum Genet 1993;53:619-28
16. van Duijn CM. Epidemiology of the dementias: Recent developments and new approaches. J Neurol Neurosurg Psychiatry 1996;60:478-88
17. Mortimer JA, van Duijn CM, Chandra V, et al. Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991;20:S28-35
18. Breitner JC, Gau BA, Welsh KA, et al. Inverse association of antiinflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurol 1994;44:227-32
19. Mrak RE, Sheng JG, Griffin WST. Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Hum Pathol 1995;26: 816-23
20. Griffin WST, Sheng JG, Royston MC, et al. Glial-neuronal interactions in Alzheimer disease: The potential role of a "cytokine cycle" in disease progression. Brain Pathol 1998;8:65-72
21. Nicoll JAR, Mrak RE, Graham DI, et al. Association of interleukin-1 gene polymorphisms with Alzheimer disease. Ann Neurol 2000;47: 365-68
22. Grimaldi LME, Casadei VM, Ferri C, et al. Association of early onset Alzheimer's disease with an interleukin-1α gene polymorphism. Ann Neurol 2000;47:361-65
23. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13
24. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1α, interleukin-1β, and interleukin-1 receptor antagonist genes. Genomics 1994;19: 382-84
25. Giulian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985;228:497-99
26. Hetier E, Ayala J, Denefle P, et al. Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res 1988;21:391-97
27. Righi M, Mori L, DeLibero G, et al. Monokine production by microglial cell clones. Eur J Immunol 1989;19:1443-48
28. Lee JC, Simon PL, Young PR. Constitutive and PMA-induced interleukin-1 production by the human astrocytoma cell line T24. Cell Immunol 1989;118:298-311
29. Freidin M, Bennett MV, Kessler JA. Cultured sympathetic neurons synthesize and release the cytokine interleukin 1β. 1992;89: 10440-43
30. Sebire G, Emilie D, Wallon C, et al. In vitro production of IL6, IL1β, and tumor necrosis factor α by human embryonic microglial and neural cells. J Immunol 1993;150:1517-23
31. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum 1995;38:221-28
32. Pociot F, Molvig J, Wogensen L, et al. TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992;22:396-402
33. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77
34. Sheng JG, Ito K, Skinner RD, et al. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 1996;17: 761-66
35. Sheng JG, Zhu SG, Griffin WST, Mrak RE. Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol 2000 (in press)
36. Stein-Behrens B, Adams K, Yeh M, Sapolsky R. Failure of β-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol Aging 1992;13:577-79
37. McKee AC, Kowall NW, Schumacher JS, Beal MF. The neurotoxicity of amyloid β protein in aged primates. Amyloid-Int J Exp Clin Inv 1998;5:1-9
38. Griffin WST, Stanley LC, Ling C, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989;86:7611-15
39. Cacabelos R, Barquero M, Garcia P, et al. Cerebrospinal fluid interleukin-1β (IL-1β) in Alzheimer's disease and neurological disorders. Meth Findings Exp Clin Pharmacol 1991;13:455-58
40. Sheng JG, Mrak RE, Griffin WST. Microglial interleukin-1α expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol 1995;21: 290-301
41. Griffin WST, Sheng JG, Roberts GW, Mrak RE: Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 1995;54: 276-81
42. Mackenzie IR, Hao C, Munoz DG. Role of microglia in senile plaque formation. Neurobiol Aging 1995;16:797-804
43. Sheng JG, Zhou XQ, Mrak RE, Griffin WST. Progressive neuronal injury associated with amyloid plaque formation in Alzheimer's disease. J Neuropathol Exp Neurol 1998;57:714-17
44. Forloni G, Demicheli F, Giorgi S, Bendotti C, Angaretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: Modulation by interleukin1. Brain Res Molec Brain Res 1992;16:128-34
45. Goldgaber D, Harris HW, Hla T, et al. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 1989;86:7606-10
46. Buxbaum JD, Oishi M, Chen HI, et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/ A4 amyloid protein precursor. Proc Natl Acad Sci USA 1992;89: 10075-78
47. Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997;388:878-81
48. Lombardi VR, Garcia M, Cacabelos R. Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes. J Neurosci Res 1998;54:539-53
49. Baskin F, Smith GM, Fosmire JA, Rosenberg RN. Altered Apolipoprotein E secretion in cytokine treated human astrocytc cultures. J Neurol Sci 1997;148:15-18
50. Das S, Potter H. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 1995;14:447-56
51. Hu J, Van Eldik LJ. Glial-derived proteins activate cultured astrocytes and enhance β-amyloid-induced glial activation. Brain Res 1999;842:46-54
52. 2-macroglobulin. J Biol Chem 1989;264:5818-25
53. 2-macroglobulin after activation of serum by immune complexes. Blood 1990;75:2388-95
54. 2-macroglobulin synthesis in rat hepatocyte primary cultures. FEBS Lett 1985;190:271-74
55. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985;17:278-82
56. Griffin WST, Sheng JG, McKenzie J, et al. Life-long overexpression of S100 in Down's syndrome: Implications tor Alzheimer pathogenesis. Neurobiol Aging 1998;2:35-42
57. Royston MC, McKenzie JE, Gentleman SM, et al. Overexpression of the neuritotrophic cytokine S100β in Down's syndrome: Correlation with patient age and β-amyloid deposition. Neuropathol Applied Neurobiol 1999;25:387-93
58. Sheng JG, Mrak RE, Griffin WST. Enlarged and phagocytic, but not primed, IL-1α-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol 1998;95:229-34
59. Sheng JG, Griffin WST, Royston CM, Mrak RE. Distribution of IL-1-immunoreactive microglia in cerebral cortical layers: Implications for neuritic plaque formation in Alzheimer's disease. Neuropathol Appl Neurobiol 1998;24:278-83
60. Griffin WST, Sheng JG, Gentleman SM, Graham Dl, Mrak RE, Roberts GW. Microglial interleukin-1α expression in human head injury: Correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci Lett 1994;176:133-36
61. Gentleman SM, Graham DI, Roberts GW. Molecular pathology of head injury: Altered β-APP metabolism and the aetiology of Alzheimer's disease. Prog Brain Res 1993;96:237-46
62. Mackenzie IR, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 1994;87:504-10
63. Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol 1997;41:402-4
64. Sheng JG, Boop FA, Mrak RE, Griffin WST. Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1α immunoreactivity. J Neurochem 1994;63:1872-79
65. Mrak RE, Sheng JG, Griffin WST. Glial cytokines in neurodegenerative conditions. In: Patterson P, Kordon C, Christen Y, eds. Research and perspectives in neurosciences: Neuro-immune interactions in neurologic and psychiatric disorders. Heidelberg: Springer-Verlag, 2000:9-17
66. Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE, Griffin WST. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci 2000;20:149-55
67. Ganter S, Northoff H, Mannel D, Gebicke-Harter PJ. Growth control of cultured microglia. J Neurosci Res 1992;33:218-30
68. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL1β. J Immunol 1993;150: 2659-67
69. Marshak DR, Pesce SA, Stanley LC, Griffin WST. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging 1992;13:1-7
70. Mrak RE, Sheng JG, Griffin WST. Correlation of astrocytic S100β expression with dystrophic neuntes in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:273-79
71. Marshak DR. S100 as a neurotrophic factor. Prog Brain Res 1990;86:169-81
72. Barger SW, Van Eldik LJ. S100β stimulates calcium fluxes in glial and neuronal cells. J Biol Chem 1992;267:9689-94
73. Li Y, Barger, SW, Liu L, Mrak RE, Griffin WST. S100β induction of the pro-inflammatory cytokine interleukin-6 in neurons: Implications for Alzheimer pathogenesis. J Neurochem 2000;74:143-50
74. Hu J, Castets F, Guevara JL, Van Eldik LJ. S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J Biol Chem 1996;271:2543-47